SEARCH RESULTS for assignee:"novartis vaccines and diagnostics"

Showing 1 to 20 of 61 results

Share this

Reel/Frame

Last Update:

Patent(s)

(X0) 15672568: AMINOHETEROARYL BENZAMIDES AS KINASE INHIBITORS

(A1) 20180028532: AMINOHETEROARYL BENZAMIDES AS KINASE INHIBITORS

Reel/Frame

Last Update:

Patent(s)

(X0) 15672568: AMINOHETEROARYL BENZAMIDES AS KINASE INHIBITORS

(A1) 20180028532: AMINOHETEROARYL BENZAMIDES AS KINASE INHIBITORS

Reel/Frame

Last Update:

Patent(s)

(X0) 15672568: AMINOHETEROARYL BENZAMIDES AS KINASE INHIBITORS

(A1) 20180028532: AMINOHETEROARYL BENZAMIDES AS KINASE INHIBITORS

Reel/Frame

Last Update:

Patent(s)

(X0) 15672568: AMINOHETEROARYL BENZAMIDES AS KINASE INHIBITORS

(A1) 20180028532: AMINOHETEROARYL BENZAMIDES AS KINASE INHIBITORS

Reel/Frame

Last Update:

Patent(s)

(X0) 15672568: AMINOHETEROARYL BENZAMIDES AS KINASE INHIBITORS

(A1) 20180028532: AMINOHETEROARYL BENZAMIDES AS KINASE INHIBITORS

Reel/Frame

Last Update:

Patent(s)

(X0) 15672568: AMINOHETEROARYL BENZAMIDES AS KINASE INHIBITORS

(A1) 20180028532: AMINOHETEROARYL BENZAMIDES AS KINASE INHIBITORS

Reel/Frame

Last Update:

Patent(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 08375248: DNA CONSTRUCT COMPRISING A VECTOR FOR EXPRESSION OF HUMAN CYTOPLASMIC CU/ZN SUPEROXIDE DISMUTASE IN E. COLI AND METHOD OF USE OF SAME

(B1) 6: DNA CONSTRUCT COMPRISING A VECTOR FOR EXPRESSION OF HUMAN CYTOPLASMIC CU/ZN SUPEROXIDE DISMUTASE IN E. COLI AND METHOD OF USE OF SAME

Reel/Frame

Last Update:

Patent(s)

(X0) 15520510: DIRECT EXPRESSION OF ANTIBODIES

(A1) 20170313765: DIRECT EXPRESSION OF ANTIBODIES

Reel/Frame

Last Update:

Patent(s)

(X0) 15881568: SAMPLE QUANTIFICATION BY DISC CENTRIFUGATION

(A1) 20180299444: SAMPLE QUANTIFICATION BY DISC CENTRIFUGATION

Reel/Frame

Last Update:

Patent(s)

(X0) 15630679: Immunogenic Proteins and Compositions

(A1) 20170296645: Immunogenic Proteins and Compositions

(B2) 1: Immunogenic Proteins and Compositions

Reel/Frame

Last Update:

Patent(s)

(X0) 15630679: Immunogenic Proteins and Compositions

(A1) 20170296645: Immunogenic Proteins and Compositions

(B2) 1: Immunogenic Proteins and Compositions

Reel/Frame

Last Update:

Patent(s)

(X0) 15977901: PSEUDOMONAS ANTIGENS AND ANTIGEN COMBINATIONS

(A1) 20180256701: PSEUDOMONAS ANTIGENS AND ANTIGEN COMBINATIONS

Reel/Frame

Last Update:

Patent(s)

(X0) 14946324: NOROVIRUS DERIVED IMMUNOGENIC COMPOSITIONS AND METHODS

(A1) 20160222066: NOROVIRUS DERIVED IMMUNOGENIC COMPOSITIONS AND METHODS

(B2) 1: NOROVIRUS DERIVED IMMUNOGENIC COMPOSITIONS AND METHODS

Reel/Frame

Last Update:

Patent(s)

(X0) 15197376: INTEGRATION OF MENINGOCOCCAL CONJUGATE VACCINATION

(A1) 20160303215: INTEGRATION OF MENINGOCOCCAL CONJUGATE VACCINATION

(B2) 1: INTEGRATION OF MENINGOCOCCAL CONJUGATE VACCINATION

Reel/Frame

Last Update:

Patent(s)

(X0) 15201651: HOMOGENOUS SUSPENSION OF IMMUNOPOTENTIATING COMPOUNDS AND USES THEREOF

(A1) 20160375132: HOMOGENOUS SUSPENSION OF IMMUNOPOTENTIATING COMPOUNDS AND USES THEREOF

(B2) 1: HOMOGENOUS SUSPENSION OF IMMUNOPOTENTIATING COMPOUNDS AND USES THEREOF

Reel/Frame

Last Update:

Patent(s)

(X0) 15201651: HOMOGENOUS SUSPENSION OF IMMUNOPOTENTIATING COMPOUNDS AND USES THEREOF

(A1) 20160375132: HOMOGENOUS SUSPENSION OF IMMUNOPOTENTIATING COMPOUNDS AND USES THEREOF

(B2) 1: HOMOGENOUS SUSPENSION OF IMMUNOPOTENTIATING COMPOUNDS AND USES THEREOF

Reel/Frame

Last Update:

Patent(s)

(X0) 15699556: Angiogenically Effective Unit Dose Of FGF And Method Of Administering

(A1) 20180221446: Angiogenically Effective Unit Dose Of FGF And Method Of Administering

Reel/Frame

Last Update:

Patent(s)

(X0) 15792519: Factor H Binding Proteins (FHBP) with Altered Properties and Methods of Use Thereof

(A1) 20180125962: Factor H Binding Proteins (FHBP) with Altered Properties and Methods of Use Thereof

Reel/Frame

Last Update:

Patent(s)

(X0) 15329818: CKIT ANTIBODY DRUG CONJUGATES

(A1) 20180193475: CKIT ANTIBODY DRUG CONJUGATES